Mumbai to host Global Pharma Business Convention soon
By Our Corporate Bureau | 23 Aug 2003
Dr P R Vavia, convention secretary of IPA 2003, says a pharmaceutical business convention of this kind and magnitude is to be held for the first time in India. Vavia and S W Deshpande, vice chairman of IPA Convention 2003, are in city to meet the pharma industry of the state to promote the event and solicit their cooperation in making it a success.
Vavia says the convention and exhibition will promote the Indian pharmaceutical industry to the world and showcase Indian capabilities and strength, and will facilitate global outsourcing, contract manufacturing, clinical trials and collaboration between Indian and overseas pharma companies.
The convention, with the theme ''Destination India: Global Pharma Business,'' offers a unique opportunity to Indian pharma companies to interact with their counterparts in the world. Indian companies involved in business related pharmaceutical field such as contract research, machinery and software development will also participate in the convention.
K Satish Reddy, managing director of Dr Reddy''s Laboratories, and Venkat Jasti, managing director of Suven Pharmaceuticals, from Hyderabad will speak at the convention among others including Dr Vinod Shah, president of American Association of Pharmaceutical Scientists (AAPS, USA) and representatives from US Food and Drug Administration.
"The interaction will revolve around the technical and commercial requirements, regulations in export markets, level of technology expertise and costs. In the currently changing global pharmaceutical scenario, the convention provides a platform for ''buyers and sellers'' of all countries to display their capabilities and source products. Similarly, this can attract contract research projects for India and the expected business generation could be to the tune of Rs 500 crore," says Subodh Priolkar, the chairman of the convention.
The delegates in the three-day meet will deliberate on various issues which include ''techno-commercial strategy for marketing in developed countries'', ''cGMPS for 21st century'', ''strategy for international markets: business potential, barriers and challenges'', ''counterfeiting: international perspective'' to mention a few.
"International companies like Aventis (UK, France, Germany), Arab Health, Asta (USA), Bectochem, Ethypharm, Sagamihara-shi (Japan), Ratiopharm, Merk (USA), Globepharm, Pfizer, MJH International (UK), Pharmascience (Canada), Medisure (Pakistan) have already confirmed their participation. All leading Indian Companies will participate in either the convention or exhibition," he says.
